Evidence map›Paper›PMID 28651629›Full record

ArticleBMC infectious diseases2017

Risk factors, person, place and time characteristics associated with Hepatitis E Virus outbreak in Napak District, Uganda.

Geofrey Amanya, Samuel Kizito, Immaculate Nabukenya, Joan Kalyango, Collins Atuheire, Hellen Nansumba, Stephen Akena Abwoye, Denis Nixon Opio, Edrisa Kibuuka, Charles Karamagi

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Epidemiology of Hepatitis E.Advances in experimental medicine and biology · 2023
    Article
  10. Article
  11. Article
  12. Hepatitis E in Bangladesh: Insights From a National Serosurvey.The Journal of infectious diseases · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Hepatitis E virus: reasons for emergence in humans.Current opinion in virology · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Geofrey AmanyaClinical Epidemiology Unit, School of Medicine, P.O Box 7072, Kampala, Uganda.
Samuel KizitoClinical Epidemiology Unit, School of Medicine, P.O Box 7072, Kampala, Uganda. somekizito@yahoo.com.
Immaculate NabukenyaEpidemiology and surveillance Division, Ministry Of Health, P.O Box 7076, Kampala, Uganda.
Joan KalyangoClinical Epidemiology Unit, School of Medicine, P.O Box 7072, Kampala, Uganda.
Collins AtuheireClinical Epidemiology Unit, School of Medicine, P.O Box 7072, Kampala, Uganda.
Hellen NansumbaClinical Epidemiology Unit, School of Medicine, P.O Box 7072, Kampala, Uganda.
Stephen Akena AbwoyeClinical Epidemiology Unit, School of Medicine, P.O Box 7072, Kampala, Uganda.
Denis Nixon OpioClinical Epidemiology Unit, School of Medicine, P.O Box 7072, Kampala, Uganda.
Edrisa KibuukaClinical Epidemiology Unit, School of Medicine, P.O Box 7072, Kampala, Uganda.
Charles KaramagiClinical Epidemiology Unit, School of Medicine, P.O Box 7072, Kampala, Uganda.
Makerere University · UGMinistry of Health · UG

Funding

Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.D43TW010540 · FIC · YALE UNIVERSITY · PI MICHELE BARRY, Eva Harris · 2017 to 2026
$15.5M
FIC NIH HHS D43 TW010540
6 · The paper itself

Abstract

backgroundHepatitis E is self-limiting, but can cause death in most at risk groups like pregnant women and those with preexisting acute liver disease. In developing countries it presents as epidemic, in 2014 Hepatitis E Virus (HEV) outbreak was reported in Napak district Uganda. The role of factors in this setting that might have propagated this HEV epidemic, including host, agent, and environmental characteristics, were still not clear. This study was therefore conducted to investigate the risk factors, person, place and time characteristics, associated with the hepatitis E virus (HEV) epidemic in Napak district.

methodsReview of line lists data for epidemiological description and matched case control study on neighborhood and age in the ratio of 1:2 were used to assess risk factors for HEV outbreak in Napak. Cluster and random sampling were used to obtain a sample size of 332, (111 cases, 221 controls). Possible interaction and confounding was assessed using conditional logistic regression.

resultsOver 1359 cases and 30 deaths were reported during 2013/2014 HEV outbreak. The mean age of patients was 29 ± years, 57.9% of cases were females. Overall case Fatality Ratio was 2.2% in general population but 65.2% in pregnant women. More than 94% of the cases were reported in the sub counties of Napak, 5.7% of cases were reported in the outside neighboring districts. The epidemic peaked in January 2014 and gradually subsided by December 2014. Risk factors found to be associated with HEV included drinking untreated water (OR 6.69, 95% CI 3.15-14.16), eating roadside food (OR 6.11, 95% CI 2.85-13.09), reported not cleaning utensils (OR 3.24, 95% CI 1.55-1.76), and being a hunter (OR 1.14, 95% CI 1.03-12.66).

conclusionThe results of this study suggest that the virus is transmitted by the feco-oral route through contaminated water. They also suggest that active surveillance and appropriate measures targeting community and routine individual health actions are important to prevent transmission and decrease the deaths.

Indexed as

AdolescentAdultCase-Control StudiesChildChild, PreschoolDisease OutbreaksFemaleHepatitis EHepatitis E virusHumansMaleMiddle AgedPregnancyRisk FactorsUgandaYoung AdultEpidemicHepatitis EUganda

Identifiers

PMID28651629
PMCPMC5485539
OpenAlexW2651003372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.